X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Recent Posts

Growing consensus on the need to improve communications with health care professionals

By Mit Spears  |    March 3, 2016
Today, the wealth of information about medicines is more comprehensive and complex than ever before. Scientific knowledge and new findings go far beyond the parameters established by Food and Drug...   Read More

Pacira settlement important step towards ensuring clinicians have access to the best available data on FDA-approved medicines

By Mit Spears  |    December 22, 2015
During last week’s FDA/CMS Summit for Biopharma Executives, I had the opportunity to discuss the many recent legal and regulatory developments regarding communicating scientific data and clinical...   Read More

ICYMI: Physicians want better information sharing with biopharmaceutical companies

By Mit Spears  |    November 23, 2015
The issue and debate around communications with health care professionals is at its very essence, a conversation about ensuring physicians have the best possible data to effectively treat...   Read More

The Pacira Case Study: Patients are better served when health care professionals have the most accurate and up-to-date medical information

By Mit Spears  |    November 13, 2015
Patients are better served when health care professionals have the most accurate and up-to-date medical information. This is true for data and information regarding FDA-approved uses and medically...   Read More

ICYMI: The Wall Street Journal Makes the Case for Sharing Truthful, Non-Misleading Information

By Mit Spears  |    August 18, 2015
On Friday, The Wall Street Journal editorialized on free speech in the context of sharing scientific and medical information, something critical for the U.S. Food and Drug Administration (FDA). ...   Read More

Embracing 21st Century Information Sharing: Defining a New Paradigm for the FDA and Communications with Health Care Professionals

By Mit Spears  |    April 1, 2015
The Food and Drug Administration (FDA) protects public health by approving new medicines for patients, ensuring unsafe treatments are not used and monitoring the evolution of scientific insights...   Read More

Biopharmaceutical Companies Face Restrictions in Sharing Scientific Information to Improve Patient Care

By Mit Spears  |    October 29, 2013
Yesterday, I had the opportunity to speak at a conference of regulatory and compliance professionals – those who are dedicated to ensuring that regulation works.   Read More

Labeling Your Health

By Mit Spears  |    July 26, 2012
A physician, equipped with the latest medical and scientific information, prescribes a medicine as the best course of treatment for a patient. The patient follows the doctor's orders, takes the...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates